The US FDA has proposed changes to the standards of identity (SOI) for foods to permit the use of salt substitutes.
Product developers would now have the flexibility to work with ingredients that are regulated by the SOI rule.
As SOIs require certain ingredients in the formulation, replacing salt with a salt substitute would be illegal.
There are over 250 SOI foods, including milk, milk chocolate, breads, cheeses and ketchup, with 80 of them specifying salt as a required or an optional ingredient.
The proposed rule does not list permitted salt substitutes but requires them to be “safe and suitable ingredients.” Potassium chloride is an often-used substitute. The agency also acknowledges the functional nature of salt.
According to the FDA, “the extent to which salt can be replaced depends on the ability of salt substitutes to replace the functions of salt in food without compromising the food safety or other essential characteristics of the food.”
The FDA''s 2021 voluntary sodium reduction targets for processed, packaged, and prepared foods seeks to reduce Americans' average daily intake of sodium from the current 3,300mg per day to 3,000 per day and ultimately to 2,300mg per day.
The proposed rule, "Use of Salt Substitutes to Reduce the Sodium Content in Standardized Foods," should be published shortly in the Federal Register, after which the industry and public will have 120 days to comment.


Airline Loyalty Programs Face New Uncertainty as Visa–Mastercard Fee Settlement Evolves
GM Issues Recall for 2026 Chevrolet Silverado Trucks Over Missing Owner Manuals
Asian Currencies Steady as Markets Await Fed Rate Decision; Indian Rupee Hits New Record Low
Firelight Launches as First XRP Staking Platform on Flare, Introduces DeFi Cover Feature
Sam Altman Reportedly Explored Funding for Rocket Venture in Potential Challenge to SpaceX
USPS Expands Electric Vehicle Fleet as Nationwide Transition Accelerates
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows
Dollar Holds Steady as Markets Shift Focus to 2026 Rate Cut Expectations
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
IKEA Expands U.S. Manufacturing Amid Rising Tariffs and Supply Chain Strategy Shift
Trump Administration to Secure Equity Stake in Pat Gelsinger’s XLight Startup
RBI Cuts Repo Rate to 5.25% as Inflation Cools and Growth Outlook Strengthens
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth
European Stocks Rise as Markets Await Key U.S. Inflation Data
Trump Hints at Major Autism Announcement, Raises Questions on Tylenol Link 



